Atrial Fibrillation (Afib) Alert Wearable App Global Market Report 2025

The atrial fibrillation (Afib) alert wearable app market size has grown rapidly in recent years. It will grow from $1.82 billion in 2024 to $2.18 billion in 2025 at a compound annual growth rate (CAGR) of 19.9%. The growth during the historic period can be attributed to the rising prevalence of atrial fibrillation, increasing adoption of wearable health technology, growing focus on preventive healthcare, expansion of real-time health tracking capabilities, and demand for personalized health monitoring.

The atrial fibrillation (Afib) alert wearable app market size is expected to see rapid growth in the next few years. It will grow to $4.44 billion in 2029 at a compound annual growth rate (CAGR) of 19.5%. The growth during the forecast period can be attributed to increasing demand for remote patient monitoring solutions, an aging global population, rising healthcare costs and the need for cost-effective solutions, expanding healthcare infrastructure, and a focus on user-friendly interfaces. Key trends in the forecast period include advancements in sensor accuracy and miniaturization, developments in artificial intelligence and machine learning algorithms, a shift toward home-based cardiac monitoring, and the introduction of multi-lead electrocardiogram (ECG) wearable devices.

The rising demand for remote patient monitoring is expected to drive the growth of the atrial fibrillation (Afib) alert wearable app market. Remote patient monitoring (RPM) uses digital technologies and electronic devices to collect health data outside traditional healthcare settings, allowing providers to monitor, track, and manage patients’ health remotely. Demand for RPM is increasing as more people live with chronic conditions such as heart disease, diabetes, and hypertension, which require continuous monitoring and timely interventions. Afib alert wearable apps support RPM by continuously tracking heart rhythms, detecting irregularities in real time, and securely transmitting data to healthcare providers, enabling timely medical intervention and effective management without frequent in-person visits. For example, in August 2023, a survey by Vivalink, a US-based healthcare technology company, found that 84% of respondents currently using RPM plan to increase usage in 2024, 45% of providers utilize RPM for acute monitoring such as hospital-at-home programs, and 77% predict RPM-based care will surpass traditional inpatient care within five years. The surging demand for remote patient monitoring is therefore driving market growth.

Key companies in the Afib alert wearable app market are focusing on innovative products such as smartwatches with real-time electrocardiogram (ECG) monitoring to detect irregular heart rhythms early and help prevent serious cardiovascular events. These smartwatches continuously track the heart’s electrical activity, helping users identify potential Afib or other heart issues early and take timely medical action. For instance, in May 2023, Samsung Electronics Co. Ltd., a South Korea-based electronics company, received FDA clearance for its Irregular Heart Rhythm Notification (IHRN) feature on the Samsung Health Monitor app. Along with the on-demand ECG function, the feature monitors heart rhythms suggestive of Afib, alerts users to potential irregularities, and prompts timely medical action. The Galaxy Watch’s BioActive Sensor continuously tracks heart activity in the background, providing real-time insights into cardiovascular health. Early detection allows individuals who may be asymptomatic to take preventive steps and consult healthcare professionals promptly. This reflects a broader trend in wearable technology, where advanced health monitoring tools are increasingly integrated into consumer devices to empower users and support proactive management of chronic conditions such as Afib.

In March 2023, HeartBeam, Inc., a US-based cardiac technology company, acquired substantially all assets of LIVMOR for an undisclosed amount. This acquisition enables HeartBeam to expand its remote cardiac monitoring capabilities by integrating LIVMOR’s FDA-cleared Halo+ Atrial Fibrillation Detection System and cloud-based platform with its existing technology, enhancing patient outcomes and reducing healthcare system costs. LIVMOR Inc. is a US-based digital health solutions company specializing in Afib alert wearable technology and remote monitoring solutions.

Major players in the atrial fibrillation (Afib) alert wearable app market are Apple Inc., Google LLC, Samsung Electronics Co. Ltd., Huawei Technologies Co. Ltd., Koninklijke Philips N.V., Omron Healthcare Inc., Garmin Ltd., iRhythm Technologies Inc., Beurer GmbH, Bittium Corporation, Eko Devices Inc., AliveCor Inc., VitalConnect Inc., VivaLNK Inc., Biotricity Inc., Preventicus GmbH, cardiacSense Ltd., HeartBeam Inc., FibriCheck BV, and CardioSignal Inc.

North America was the largest region in the atrial fibrillation (Afib) alert wearable app market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in atrial fibrillation (Afib) alert wearable app report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The atrial fibrillation (AFib) alert wearable app market research report is one of a series of new reports that provides atrial fibrillation (AFib) alert wearable app market statistics, including atrial fibrillation (AFib) alert wearable app industry global market size, regional shares, competitors with the atrial fibrillation (AFib) alert wearable app market share, atrial fibrillation (AFib) alert wearable app market segments, market trends, and opportunities, and any further data you may need to thrive in the atrial fibrillation (AFib) alert wearable app industry. This atrial fibrillation (AFib) alert wearable app market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An atrial fibrillation (Afib) alert wearable app is a mobile or wearable technology designed to monitor heart rhythms in real time and detect irregularities associated with atrial fibrillation. It provides immediate notifications when abnormal heart activity is detected, enabling timely intervention. The app integrates with wearable devices to continuously track cardiac patterns, support proactive heart health management, offer insights into trends over time, facilitate data sharing with healthcare providers, and guide lifestyle or treatment decisions based on real-time heart rhythm information.

The primary product types of atrial fibrillation (Afib) alert wearable apps are standalone apps and integrated wearable devices. A standalone app operates independently on a device, performing all core functions without requiring a companion phone or external software. These apps are compatible with platforms such as iOS, Android, and others, and are distributed through app stores, direct sales, and third-party vendors. They are used for applications including remote patient monitoring, personal health tracking, clinical use, and more, and serve end-users such as hospitals, clinics, homecare settings, individuals, and others.

The countries covered in the atrial fibrillation (Afib) alert wearable app market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The atrial fibrillation (Afib) alert wearable app market consists of revenues earned by entities by providing services such as remote patient monitoring, health data analytics and reporting, medication and lifestyle management support, integration with electronic health records, insurance and clinical trial support, and user engagement and coaching. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial fibrillation (Afib) alert wearable app market also includes sales of smartwatches with electrocardiogram (ECG) sensors, portable electrocardiogram (ECG) monitors, wearable cardiac patches, hybrid smartwatches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.